ERIKA SULLIVAN: Open Payments
NPI 1568828812 · COEUR D ALENE, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,023 in 94 payments from 20 companies in 2025. Trend: 2023 $1,807 · 2024 $2,473 · 2025 $2,023
Food & beverage: $2,023
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 32 | $401 |
| Abbott Laboratories | 4 | $237 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $197 |
| Janssen Pharmaceuticals, Inc | 4 | $193 |
| AstraZeneca Pharmaceuticals LP | 8 | $184 |
| Axsome Therapeutics, Inc. | 5 | $117 |
| Amgen Inc. | 4 | $83 |
| PFIZER INC. | 4 | $81 |
| Lilly USA, LLC | 3 | $71 |
| Vanda Pharmaceuticals Inc. | 3 | $63 |
Products named: FREESTYLE LIBRE 3, CAPLYTA, SPRAVATO, UBRELVY, VRAYLAR, FARXIGA, AIRSUPRA, Auvelity.
Industry payments across ID — which companies pay providers there.
